KRAS and pancreatic neoplasm: To further test the hypothesis that K-ras transformation activates NOX and renders the transformed cells vulnerable to NOX inhibitor, DPI, a potent and specific inhibitor of flavoproteins including NAD(P)H oxidase [22], in pancreatic cancer cells and parental E6E7 cells was compared.